Physical training increases osteoprotegerin in postmenopausal women
- PMID: 21823052
- DOI: 10.1007/s00774-011-0304-6
Physical training increases osteoprotegerin in postmenopausal women
Abstract
The purpose of this study was to explore whether mechanical loading by exercise over a 1-year period in postmenopausal women had an effect on the receptor activator for nuclear factor kappa B ligand/osteoprotegerin (RANKL/OPG) system or the levels of the Wnt-signaling antagonist sclerostin. A total of 112 postmenopausal were randomized to either sedentary life (controls) or physical activity (training group). Ninety-two women fulfilled the study protocol. The training program consisted of three fast 30-min walks and one or two 1-h aerobic training sessions per week. The effect on the bone mineral density of the hip assessed with dual X-ray absorptiometry was positive as reported earlier. Blood samples were taken from participants at baseline and after 1 year and serum levels of OPG, RANKL and sclerostin were quantified together with the bone metabolism markers C-terminal telopeptide of collagen type I (CTX) and bone-specific alkaline phosphatase (BALP). The results were analyzed using an analysis of covariance model using baseline values as the covariate. The training group displayed a clear mean increase of OPG +7.55 pg/ml compared to controls (p = 0.007). The mean changes for RANKL +0.19 pg/ml (square-root transformed data) and sclerostin +0.62 pmol/l were non-significant (p = 0.13 and p = 0.34). The changes in bone turnover markers CTX and BALP showed a tendency to decrease in the training group versus controls but the changes were small and non-significant. Although our study is limited in number of participating women, we have been able to show an OPG-associated, and RANKL- and sclerostin-independent, training-induced inhibition of postmenopausal bone loss.
Similar articles
-
Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis.Maturitas. 2013 Apr;74(4):363-8. doi: 10.1016/j.maturitas.2013.01.005. Epub 2013 Feb 4. Maturitas. 2013. PMID: 23391500
-
Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.Gerontology. 2009;55(3):275-80. doi: 10.1159/000196280. Epub 2009 Jan 22. Gerontology. 2009. PMID: 19158438
-
The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial.Br J Nutr. 2014 Jul 14;112(1):55-60. doi: 10.1017/S0007114514000671. Epub 2014 Apr 29. Br J Nutr. 2014. PMID: 24780728 Clinical Trial.
-
Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.J Clin Endocrinol Metab. 2013 Aug;98(8):3206-12. doi: 10.1210/jc.2013-1402. Epub 2013 Jun 20. J Clin Endocrinol Metab. 2013. PMID: 23788684 Clinical Trial.
-
Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.Clin Exp Rheumatol. 2011 Nov-Dec;29(6):921-5. Epub 2011 Dec 22. Clin Exp Rheumatol. 2011. PMID: 22032557
Cited by
-
Effect of Resistance Exercise on Serum Osteoprotegerin Levels and Insulin Resistance in Middle-Aged Women with Metabolic Syndrome.Med Sci Monit. 2018 Dec 24;24:9385-9391. doi: 10.12659/MSM.911548. Med Sci Monit. 2018. PMID: 30582576 Free PMC article.
-
RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling.Biomed Res Int. 2020 Feb 19;2020:6910312. doi: 10.1155/2020/6910312. eCollection 2020. Biomed Res Int. 2020. PMID: 32149122 Free PMC article. Review.
-
Effect of Ginseng Extracts on the Improvement of Osteopathic and Arthritis Symptoms in Women with Osteopenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Nutrients. 2021 Sep 24;13(10):3352. doi: 10.3390/nu13103352. Nutrients. 2021. PMID: 34684351 Free PMC article. Clinical Trial.
-
Circulating sclerostin is not suppressed following a single bout of exercise in young men.Physiol Rep. 2018 May;6(10):e13695. doi: 10.14814/phy2.13695. Physiol Rep. 2018. PMID: 29845770 Free PMC article. Clinical Trial.
-
Tai chi for treating osteopenia and primary osteoporosis: a meta-analysis and trial sequential analysis.Clin Interv Aging. 2019 Jan 3;14:91-104. doi: 10.2147/CIA.S187588. eCollection 2019. Clin Interv Aging. 2019. PMID: 30655662 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources